Current concepts in the evaluation and treatment of neurofibromatosis type II.
This article presents the current diagnostic and treatment options for the hereditary disease neurofibromatosis type II, reviews clinical presentation and diagnosis, highlights indications for and methods of clinical and genetic screening, discusses treatment approaches for surgery and stereotactic radiation, and summarizes potential future therapeutic avenues.
Neff
Brian A
BA
Department of Otolaryngology, Mayo Clinic, Rochester, MN, USA.
Welling
D Bradley
DB
D019299:Decompression, Surgical; D005820:Genetic Testing; D034381:Hearing Loss / Q000534:rehabilitation; D006801:Humans; D008279:Magnetic Resonance Imaging; D016518:Neurofibromatosis 2 / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology / Q000532:radiotherapy / Q000628:therapy*